title: [Efficacy and safety in the use of doxazosin (cardura) in the treatment of patients with benign prostatic hypertrophy (bph)].
authors.forename: N A
authors.initials: NA
authors.lastname: Lopatkin
authors.forename: Iu G
authors.initials: IuG
authors.lastname: Aliaev
authors.forename: M I
authors.initials: MI
authors.lastname: Kogan
authors.forename: O B
authors.initials: OB
authors.lastname: Loran
authors.forename: E B
authors.initials: EB
authors.lastname: Mazo
authors.forename: V N
authors.initials: VN
authors.lastname: Stepanov
mesh_terms: D018674:Adrenergic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D017292:Doxazosin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011788:Quality of Life; D012720:Severity of Illness Index
chemical_list: D018674:Adrenergic Antagonists; D017292:Doxazosin